The global Bioimpedance Devices Market is expected to exceed US$ 492.1 Million in 2022. The market is expected to reach US$ 715.1 Million by 2028, growing at a healthy 6.4% CAGR.
Increasing CKD disease cases are expected to fuel the growth of the Bioimpedance Devices Market over the forecast period. Chronic kidney disease (CKD) is a medical condition that causes a progressive loss of kidney function over time. According to the National Kidney Foundation, Inc., 30 million American adults have Chronic Kidney Disease (CKD), and millions more are at high risk of developing the disease.
Request a report sample to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5563
The best overall index for studying kidney function is the Glomerular filtration rate (GFR). Bioelectrical impedance, also known as bioimpedance, is used to improve estimation of glomerular filtration rate and muscle mass in non-diabetic patients with chronic kidney disease. Appendicular lean mass can also be measured using bioelectrical impedance analysis (BIA) (ALM).
The performance of these equations, which include ALM BIA to estimate renal inulin clearance (GFR INU), can be compared to demographic variables and used to make dietary changes for renal disease (MDRD) treatment.
In recent years, widespread online marketing channels have greatly increased the sale of portable and hand-held Bioimpedance devices. For example, a research study estimated that in 2015, approximately 70% of the population in the United States relied on online shopping portals to purchase various items.
To ensure better access to their devices and increase sales, vendors in the Bioimpedance devices market are focusing on promotional strategies and online marketing. Devices sold online also assist vendors in lowering operational and distribution costs.
The online marketing channel also enables vendors to provide information about their portfolio of devices and gain access to both global and local markets. Furthermore, these online marketing websites offer a diverse range of high-quality Bioimpedance systems at more affordable prices.
The majority of Bioimpedance Devices manufacturers are focusing on developing portable and affordable products. Because of their numerous advantages, portable bioimpedance devices are becoming increasingly popular. Bioimpedance Devices, for example, are noninvasive, reasonable, safe, and simple to use.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-5563
Because these devices are lightweight, they are widely used in home-based healthcare settings to monitor the health of the entire family. All of these factors are expected to drive demand for portable bioimpedance devices over the forecast period. People are increasingly opting for portable/hand-held bioimpedance devices when travelling.
For example, the demand for the ImpediMed SFB7, a hand-held Bioimpedance device, is increasing because it is portable. Over the forecast period, technological advancements to improve the quality of Bioimpedance devices and increase patient compliance are also expected to drive market growth.
Because they can measure impedances at different frequencies, multiple-frequency bioimpedance devices are highly preferred. This allows for a more accurate and efficient calculation of fat free mass, total body water, and intra and extracellular water.
Only one frequency Bioimpedance devices can calculate fat free mass and total body water but cannot estimate intra and extracellular body water. Increased popularity and awareness of multiple-frequency Bioimpedance devices are expected to drive market growth for Bioimpedance devices during the forecast period.
FMI has segmented the global Bioimpedance Devices market by product type, modality and end user. The Bioimpedance Devices market, by product type, is segmented into Single-frequency Bioimpedance Devices and Multiple-frequency Bioimpedance Devices. By Modality, the Bioimpedance devices market is segmented into Wired Bioimpedance Devices and Wireless Bioimpedance Devices.
Bioimpedance Devices, by end users, are segmented into Hospitals, Specialty Clinics, Rehabilitation Centers and Others. Region-wise segmentation includes North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. The wired Bioimpedance devices segment in the Bioimpedance Devices market is expected to witness a significant growth during the forecast period.
The report tracks some of the key companies operating in the Bioimpedance Devices market including General Electric Company, Omron Corporation, Fresenius Medical Care, ImpediMed Limited, SELVAS AI Inc., Tanita Corporation, RJL Systems, Inc., Maltron International Ltd., Bodystat Limited and SMT Medical GmbH.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
For Sales Enquiries: email@example.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs